Literature DB >> 10881135

[RIII mefloquine resistance in children with falciparum malaria in Manaus, AM, Brazil].

E Noronha1, M G Alecrim, G A Romero, V Macêdo.   

Abstract

We report the occurrence of resistance to mefloquine 20mg/day in 51 children with falciparum malaria treated, at reference center of Manaus, Brazil, from October to December 1997. All children were evaluated at day 3, 5, 7, 14, 21, 28 and 35 of treatment. Clinical and parasitological cure criteria were adopted. The incidence of RIII mefloquine resistance was 5.9% (IC 95% 1.5-17.2). The cure/resistance proportion was 20:1 and cure/severity was 62:1. These findings suggest the importance of mefloquine resistance within this group of children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881135

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

Review 1.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Challenges for malaria elimination in Brazil.

Authors:  Marcelo U Ferreira; Marcia C Castro
Journal:  Malar J       Date:  2016-05-20       Impact factor: 2.979

3.  Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.

Authors:  Julie Gutman; Michael Green; Salomon Durand; Ofelia Villalva Rojas; Babita Ganguly; Wilmer Marquiño Quezada; Gregory C Utz; Laurence Slutsker; Trenton K Ruebush; David J Bacon
Journal:  Malar J       Date:  2009-04-09       Impact factor: 2.979

4.  Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon.

Authors:  Lilian R Pratt-Riccio; Yonne F Chehuan; Maria José Siqueira; Maria das Graças Alecrim; Cesare Bianco-Junior; Pierre Druilhe; Philippe Brasseur; Maria de Fátima Ferreira-da-Cruz; Leonardo J M Carvalho; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2013-08-12       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.